We analyzed the impact of insulin-treated compared to non-insulin-treated diabetes mellitus in patients undergoing PCI of a de novo lesion on the outcome of drug-coated balloons versus drug-eluting stents in the diabetic population of the randomized BASKET-SMALL 2 trial. The gene discussed is INS; the disease is diabetes mellitus.